HIGH · 8.8

CVE-2023-6515

Authorization Bypass Through User-Controlled Key vulnerability in Mia Technology Inc. MİA-MED allows Authentication Abuse. This issue affects MİA-MED: before 1.0.7.

Vulnerability Description

Authorization Bypass Through User-Controlled Key vulnerability in Mia Technology Inc. MİA-MED allows Authentication Abuse. This issue affects MİA-MED: before 1.0.7.

CVSS Score

8.8

HIGH

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality
HIGH
Integrity
HIGH
Availability
HIGH

Affected Products

VendorProductVersions
MiateknolojiMia-Med< 1.0.7

Related Weaknesses (CWE)

References

FAQ

What is CVE-2023-6515?

CVE-2023-6515 is a vulnerability with a CVSS score of 8.8 (HIGH). Authorization Bypass Through User-Controlled Key vulnerability in Mia Technology Inc. MİA-MED allows Authentication Abuse. This issue affects MİA-MED: before 1.0.7.

How severe is CVE-2023-6515?

CVE-2023-6515 has been rated HIGH with a CVSS base score of 8.8/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-6515?

Check the references section above for vendor advisories and patch information. Affected products include: Miateknoloji Mia-Med.